title: Reversal of novel oral anticoagulants in patients with major bleeding.
abstract: Novel oral anticoagulants (NOACs) that directly inhibit thrombin (dabigatran) or factor Xa (rivaroxaban, apixaban, edoxaban) are effective therapies for the prevention and treatment of thromboembolism with reduced bleeding complications compared with warfarin for some indications. However, specific antidotes to reverse the anticoagulant activity of NOACs in the event of major bleeding are not available. Evidence supporting non-specific prohemostatic therapies (prothrombin complex concentrate [PCC], activated prothrombin complex concentrate [aPCC], recombinant factor VIIa) in this setting is limited to healthy human volunteers, animal models, and in vitro studies. Clinical outcome data are lacking. Administration of PCC or aPCC may be considered in addition to supportive measures for patients with severe or life-threatening bleeding. Clinical studies are needed to establish the efficacy and safety of these treatments. Target-specific antidotes are in development and hold promise for NOAC reversal, but require further investigation.
authors: Department of Medicine, McMaster University, Hamilton, ON, Canada.
authors: Deborah M
authors: DM
authors: Siegal
authors: Adam
authors: A
authors: Cuker
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced* / Q000188:drug therapy*; D006490:Hemostatics / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D013923:Thromboembolism / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D006490:Hemostatics
references: J Thromb Haemost. 2008 Sep;6(9):1542-9
references: 18624979
references: J Thromb Haemost. 2004 Oct;2(10):1700-8
references: 15456478
references: PLoS One. 2013 Nov 11;8(11):e78696
references: 24244342
references: Drug Metab Dispos. 2009 May;37(5):1056-64
references: 19196845
references: Circulation. 2012 Nov 13;126(20):2381-91
references: 23071159
references: Blood. 2012 Feb 16;119(7):1757-67
references: 22117051
references: Thromb Haemost. 2004 Jun;91(6):1090-6
references: 15175794
references: Thromb Res. 2011 May;127(5):457-65
references: 21277622
references: Drug Metab Dispos. 2009 Jan;37(1):74-81
references: 18832478
references: J Thromb Haemost. 2005 Mar;3(3):514-21
references: 15748242
references: Anesthesiology. 2012 Jan;116(1):94-102
references: 22042412
references: Thromb Haemost. 2012 Feb;107(2):379-87
references: 22187012
references: Spine (Phila Pa 1976). 2012 Jun 15;37(14):E863-5
references: 22343277
references: Ann Pharmacother. 2012 Sep;46(9):e21
references: 22872748
references: J Clin Pharmacol. 2010 Jul;50(7):743-53
references: 20081065
references: J Thromb Haemost. 2011 Jan;9(1):133-9
references: 20946166
references: Thromb Haemost. 2010 Dec;104(6):1263-71
references: 20978714
references: Haemophilia. 2002 Mar;8(2):83-90
references: 11952842
references: Br J Clin Pharmacol. 2007 Sep;64(3):292-303
references: 17506785
references: Br J Clin Pharmacol. 2013 Feb;75(2):476-87
references: 22759198
references: Stroke. 2011 Dec;42(12):3594-9
references: 21998060
references: Thromb Haemost. 2012 Aug;108(2):217-24
references: 22627883
references: Circulation. 2011 Oct 4;124(14):1573-9
references: 21900088
references: Thromb Haemost. 2010 Jun;103(6):1116-27
references: 20352166
references: Lancet. 2007 Aug 4;370(9585):439-48
references: 17679021
references: Thromb Haemost. 2011 Sep;106(3):429-38
references: 21800002
references: Clin Chem Lab Med. 2011 May;49(5):761-72
references: 21288169
references: Eur J Clin Pharmacol. 2005 Dec;61(12):873-80
references: 16328318
references: Clin Pharmacokinet. 2010 Apr;49(4):259-68
references: 20214409
references: Clin Pharmacokinet. 2009;48(1):1-22
references: 19071881
references: Thromb Haemost. 2012 May;107(5):916-24
references: 22398784
references: Drug Metab Dispos. 2008 Feb;36(2):386-99
references: 18006647
references: Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001886
references: 21412876
references: Thromb Haemost. 2010 Apr;103(4):815-25
references: 20135059
references: N Engl J Med. 2010 Nov 4;363(19):1791-800
references: 21047223
references: J Thromb Haemost. 2012 Sep;10(9):1830-40
references: 22817470
references: Chest. 2012 Feb;141(2 Suppl):e44S-e88S
references: 22315269
references: Blood Coagul Fibrinolysis. 2012 Mar;23(2):138-43
references: 22227958
references: Thromb Haemost. 2011 Feb;105(2):371-8
references: 21103660
references: Thromb Haemost. 2011 Jun;105(6):1080-90
references: 21544313
references: Clin Pharmacol Ther. 2009 Aug;86(2):139-46
references: 19553932
references: Thromb Haemost. 2012 Feb;107(2):253-9
references: 22186946
references: Thromb Haemost. 2009 Apr;101(4):780-2
references: 19350128
references: Transfusion. 2012 Jan;52(1):160-5
references: 21762464
references: J Thromb Haemost. 2008 May;6(5):820-9
references: 18315548
references: Anesthesiology. 2008 Dec;109(6):1063-76
references: 19034103
references: Clin Pharmacol Ther. 2005 Oct;78(4):412-21
references: 16198660
references: BMJ. 2012 Nov 13;345:e7498
references: 23150473